Attorneys who counsel health-care industry clients will need to be on their toes in 2018, Bloomberg Law advisory board members told us in response to our survey to determine the top 10 health law issues for this year.
Novel legal issues could arise quickly, depending on moves the Trump administration makes, they said. The uncertainty board members warned last year would prevail throughout 2017 could turn into chaos in 2018, they said.
The No. 1 issue on board members’ minds, like last year, was health-care policy. This wasn’t surprising, given the Republican obsession with killing the Affordable Care Act. Although Congress failed last summer to repeal the law, administrative action and the tax reform law’s repeal of the individual mandate penalty will effectively strip it of its effectiveness, board members said. They added that they don’t see any good proposals for a replacement arising in 2018.
The rest of the list was, in most respects, as what might have been expected, with fraud and abuse at No. 2 and both Medicare and Medicaid in prominent positions. Board members warned, however, that these and the other top 10 issues—health information technology, health-care industry consolidation, governance, antitrust, and taxation—are interwoven to an extent not seen previously.
Governance issues will be a central concern, they said, warning that technology is now a governing board issue. Directors and corporate officers must be as conversant with technological concerns as they have been with regulatory compliance issues in the past. Medicare and Medicaid reimbursement issues, additionally, are driving much of the consolidation among providers, they said.
Get a sense of where the health industry is headed in 2018 by reading the full article, as well as Bloomberg Law’s legislative and regulatory health-care outlooks here.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)